INcidence of Deep vein thRombosis after Arthroplasty of the shoulder

INcidence of Deep vein thRombosis after Arthroplasty of the shoulder - INDRA-P

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON31366

Enrollment

100

Registered

2007-08-02

Start date

2008-03-01

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

venous thromboembolism blood clot

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: arthroplasty shoulder Over 18 years

Exclusion criteria

Exclusion criteria: Anticoagulantia (heparin-derivates, Vit K antagonists) Follow-up not feasible no informed consent Previous trombosis

Design outcomes

Primary

Measure	Time frame
De onderzoeksperiode is 6 weken. Primaire uitkomstmaat is de incidentie van postoperatieve symptomatische en asymptomatische tromboembolische complicaties aangetoond middels uitgebreide compressie echo-duplex.	—

Secondary

Measure	Time frame
Secundaire uitkomstmaten zijn de incidentie van bloedingen gedefinieerd als: Een majeure bloeding peri-operatief (Hb daling > 2 mmol/l of transfusie behoefte) Een kleine bloeding (elke andere zichtbare bloeding)	—

Countries

Netherlands

Outcome results